Conferences - Results from #8700

Viewing 8701-8720 of 11775 articles

SIU 2017: Translational Observations from Mutation Profiling of Muscle Invasive Bladder Cancer

SIU 2017: ProtecT in 2017: What Have We Learnt?

SIU 2017: MRI As a Triage Test in Prostate Cancer Diagnostic Algorithm in Biopsy - Naïve Men: A Prospective Study

SIU 2017: Economic Effectiveness of Urinary PCA3 Test in Cases of Serum PSA Level 4-10 Ng/Ml

SIU 2017: Neoadjuvant Chemo - When, What and Why?

SIU 2017: Can Genetic Analysis in Bladder Cancer Enhance Decision Making

SIU 2017: Atypical Small Acinar Proliferation: Progression to Clinically Significant Prostate Cancer?

SIU 2017: Biojet – Real Time TRUS/MRI Fusion Biopsy of The Prostate: Value of Combining Targeted and Systematic Biopsies

SIU 2017: Transperineal Template-Guided Mapping Biopsy and Multiparametric MRI for Detection of Clinically Significant Prostate Cancer in Patients after initial Negative Trans-rectal Ultrasound-Guided Biopsy

SIU 2017: Combined Clinical Parameters and Multiparametric MRI for Advanced Risk Modeling of Prostate Cancer - Patient-Tailored Risk Stratification Can Reduce Unnecessary Biopsies

SIU 2017: Correlation of mpMRI Contours with 3-Dimensional 5mm Transperineal Prostate Mapping Biopsy within the PROMIS Trial Pilot: What Margins Are Required?

SIU 2017: Outcomes of Cognitive MRI Targeted TRUS Biopsy of Prostate

SIU 2017: Correlation between Multiparametric MRI PIRADS Scores and Prostate Carcinoma Grade Grouping on Transperineal Template +/- Targeted Biopsy

SIU 2017: Prostate Cancer Can Be Detected Even in Patients with Decreased PSA after Antibiotic Therapy

SIU 2017: Automatic Grading of Prostate Cancer using the Gleason Grading Groups

SIU 2017: Presence of Only Clinical Stage T2c Is Not Sufficient to be Classified as High Risk Prostate Cancer

SIU 2017: GA-PSMA-PET/CT VS. Choline-PET/CT in Malignant Prostate Cancer - A Systematic Review

SIU 2017: Comparison of 68Ga-PSMA-PETCT with Multiparametric MRI for Staging High Risk Prostate Cancer

SIU 2017: Comparison of Multiparametric and Biparametric MRI Cognitive Targeted First Round Prostate Biopsy for Patients with a PSA Level under 10 Ng/Ml

SIU 2017: Impact of Canadian Task Force on Preventative Health Care Recommendation Against PSA Screening on Radical Prostatectomy Results

431
432
433
434
435
436
437
438
439
440